Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Opinion in Hematology|May 23, 2013
Early T-cell precursor acute lymphoblastic leukaemiaJ Erika Haydu, Adolfo A FerrandoBlood Advances|July 23, 2024
The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomasJ Erika Haydu, Jeremy S AbramsonMolecular and Cellular Biology|October 13, 2006
Cell confluence regulates hepatocyte growth factor-stimulated cell morphogenesis in a beta-catenin-dependent mannerShuta Ishibe, J Erika Haydu, Akashi Togawa, et al.Blood|April 19, 2012
An activating intragenic deletion in NOTCH1 in human T-ALLJ Erika Haydu, Kim De Keersmaecker, Mary Kaye Duff, et al.Blood|July 30, 2008
K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitorsThomas Kindler, Melanie G Cornejo, Claudia Scholl, et al.The Journal of Experimental Medicine|December 14, 2011
ETV6 mutations in early immature human T cell leukemiasPieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.Nature Medicine|September 22, 2015
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemiaDaniel Herranz, Alberto Ambesi-Impiombato, Jessica Sudderth, et al.Nature Genetics|January 14, 2014
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasTeresa Palomero, Lucile Couronné, Hossein Khiabanian, et al.Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.Pageof 2